Oculis Holding AG (NASDAQ:OCS - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $18.10 and last traded at $17.57, with a volume of 58391 shares. The stock had previously closed at $17.56.
Analyst Ratings Changes
Separately, HC Wainwright reaffirmed a "buy" rating and set a $30.00 price target on shares of Oculis in a research report on Monday. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Oculis presently has an average rating of "Buy" and a consensus price target of $29.20.
View Our Latest Stock Report on OCS
Oculis Trading Up 0.5 %
The business's 50-day simple moving average is $16.32 and its two-hundred day simple moving average is $13.75. The company has a quick ratio of 4.02, a current ratio of 4.02 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $714.90 million, a price-to-earnings ratio of -9.15 and a beta of -0.33.
About Oculis
(
Get Free Report)
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis.
Read More
Before you consider Oculis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oculis wasn't on the list.
While Oculis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
